MolecuLight Inc., a global medical device company pioneering point-of-care fluorescence imaging for measuring bacterial load ...

Hyperbaric Oxygen Therapy HBOT has been a topic of growing interest among healthcare professionals athletes and individuals seeking innovative ways to enhance recovery By placing patients in a pressur ...

Strategic financing will enable MolecuLight to further accelerate commercialization PITTSBURGH, Jan. 6, 2025 /PRNewswire/ -- ...

Analyst Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on Mediwound (MDWD – Research Report) and keeping the price target ...

MedicosBiotech proudly announces its recognition at CES 2025, the world's premier technology event, as a recipient of the ...

IMC-2032 is under clinical development by ImmuneCyte and currently in Phase I for Premature Ageing. According to GlobalData, Phase I drugs for Premature Ageing does not have sufficient historical data ...

IMC-2017 is under clinical development by ImmuneCyte and currently in Phase I for Spinal Cord Disorders. According to GlobalData, Phase I drugs for Spinal Cord Disorders have an 86% phase transition ...

Future Outlook Projection: The research concludes with a forward-looking objective, projecting the future outlook of the industry. This involves synthesizing insights gained throughout the analysis to ...

Advanced wound dressings (for example, alginate, film, foam, hydrocolloid and hydrogel dressings) regulate the wound surface by retaining moisture or absorbing exudate, so protecting the wound base ...

Peripheral artery disease is the narrowing and blocking of the arteries in the legs. This process of furring up of the blood ...

Fernando Morenilla, a nurse at the Duanes de Mar health centre, has been awarded for his final residency work. The research ...

Approximately one in 1,000 patients with diabetes have a major amputation each year, corresponding to 5-6 times higher risk ...